Advertisement
Screener

Amylyx Pharmaceuticals, Inc. (AMLX) Pre-Tax Margin

Amylyx Pharmaceuticals, Inc. (AMLX) Pre-Tax Margin

  • 2024-12-31: Pre-Tax Margin 5741.50%.
  • 2024-09-30: Pre-Tax Margin -17476.92%.
  • 2024-06-30: Pre-Tax Margin 7106.55%.
  • 2024-03-31: Pre-Tax Margin -133.74%.

Complete source-backed pre-tax margin history.

Available history
2021-09-30 to 2024-12-31
Data captured

Historical Pre-Tax Margin

DatePre-Tax Margin
2024-12-315741.50%
2024-09-30-17476.92%
2024-06-307106.55%
2024-03-31-133.74%
2023-12-315.97%
2023-09-3021.82%
2023-06-3024.44%
2023-03-311.96%
2022-12-31-192.48%
2022-09-30-15617.68%
2021-09-30-8120.00%

Annual Pre-Tax Margin

DatePre-Tax Margin
2024-12-31-345.81%
2023-12-3114.26%
2022-12-31-888.89%
2021-12-31-30852.98%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47
Arcus Biosciences, Inc. (RCUS)United States$3.188B-8.52
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Organon & Co. (OGN)United States$3.603B17.03
Dyne Therapeutics, Inc. (DYN)United States$3.084B-7.09
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
AbCellera Biologics Inc. (ABCL)$3.879B-14.59
PRECIGEN, INC. (PGEN)United States$2.757B-12.94